Halobetasol and Tazarotene and Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
Determining the interaction of Halobetasol and Tazarotene and Kisqali Femara Co-Pack 600 mg-2.5 mg Dose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: halobetasol / tazarotene topical
Brand name: Duobrii
Synonyms: Halobetasol and tazarotene topical
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Halobetasol and Tazarotene-Kitabis Pak
- Halobetasol and Tazarotene-Kitabis Pak inhalation
- Halobetasol and Tazarotene-Klofensaid II
- Halobetasol and Tazarotene-Klonopin
- Halobetasol and Tazarotene-Klonopin Wafer
- Halobetasol and Tazarotene-Klonopin Wafers
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Halobetasol and tazarotene topical
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Halobetasol Cream
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Halobetasol Cream and Ointment
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Halobetasol Cream and Ointment with Lactic Acid Cream
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Halobetasol Foam
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Halobetasol Lotion